Fundraising FoxMithril Capital Management — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.
BiotechHealthtechMedical DevicesLexington, US
Jay Caplan(Founder)inHarith Rajagopalan(Co-Founder and CEO)inLISA DAVIDSON(Executive Officer)inDiane Marcou(Executive Officer)in
BoardAllan Will(Director)inNimesh Shah(Director)in
Board seatAjay Royan· per SEC Form D
Co-investorsBessemer Venture PartnersCatalio Capital Management, LPEmergent Medical Partners, LLPGeneral CatalystDomain AssociatesPolaris Partners+1 more
.png)
AiFi builds camera-based computer vision software that turns physical retail and venue spaces into autonomous, checkout-free environments.
Co-investorsAmino CapitalCSC UpshotSeaX VenturesZMT CapitalCERVIN VENTURESQualcomm Ventures+1 more
-2.png)
AiFi uses AI and computer vision to make physical spaces searchable, observable, and understandable, providing real-time insights for facility and space operators without manual audits.
AI & Machine LearningEnterprise SoftwareIoTRetail Tech
Steve Gu(Founder & CEO)Ying Zheng(Founder)inJoão Diogo Falcão(CEO)
Co-investorsAmino CapitalBRC InnovationCervinCommunitas Capital PartnersDuke Capital PartnersEvolution Ventures+10 more
New cardiac scanning method for diagnostics.
BiotechMason, US
Peeyush Shrivastava(Chief Executive Officer)inManny Setegn(Cofounder)inManjit Singh(Vice President, Infrastructure Operations)Vineet Erasala(Vice President, Research and Development)inChandan Srivastava(Chief Financial Officer)inEmmanuel Setegn(Vice President, Engineering)
Co-investorsAlumni VenturesCincyTechJobsOhio VenturesOhio Innovation FundRaptor GroupTDK Ventures+1 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.